Core Laboratories (CLB) News Today $12.32 +0.65 (+5.52%) Closing price 05/2/2025 03:59 PM EasternExtended Trading$12.34 +0.02 (+0.12%) As of 05/2/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Core Laboratories (NYSE:CLB) Sets New 1-Year Low - Here's WhyCore Laboratories (NYSE:CLB) Reaches New 52-Week Low - What's Next?May 3 at 6:18 AM | marketbeat.comCore Laboratories Inc. (NYSE:CLB) Holdings Decreased by Earnest Partners LLCEarnest Partners LLC reduced its stake in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 1.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,684,720 shares of the oilApril 30, 2025 | marketbeat.comT. Rowe Price Investment Management Inc. Grows Position in Core Laboratories Inc. (NYSE:CLB)T. Rowe Price Investment Management Inc. grew its position in Core Laboratories Inc. (NYSE:CLB - Free Report) by 4.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,158,702 shares of the oil and gas company's stock after purchasing an additionApril 29, 2025 | marketbeat.comInvesco Ltd. Has $4.37 Million Position in Core Laboratories Inc. (NYSE:CLB)Invesco Ltd. lessened its holdings in Core Laboratories Inc. (NYSE:CLB - Free Report) by 25.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 252,324 shares of the oil and gas company's stock after selling 84,April 28, 2025 | marketbeat.comCore Laboratories (NYSE:CLB) Stock Rating Lowered by StockNews.comApril 28, 2025 | americanbankingnews.comCore Laboratories price target lowered to $13 from $15 at StifelApril 27, 2025 | markets.businessinsider.comNatixis Acquires Shares of 30,050 Core Laboratories Inc. (NYSE:CLB)Natixis bought a new position in Core Laboratories Inc. (NYSE:CLB - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor bought 30,050 shares of the oil and gas company's stock, valued at approximately $520,000. Natixis owned 0.06April 27, 2025 | marketbeat.comCore Laboratories Inc. (NYSE:CLB) Shares Purchased by JPMorgan Chase & Co.JPMorgan Chase & Co. boosted its stake in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 161.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 108,028 shares of the oil and gas company's sApril 27, 2025 | marketbeat.comCore Laboratories Inc. (CLB) Q1 2025 Earnings Call TranscriptApril 26, 2025 | seekingalpha.comRaymond James Financial Inc. Invests $6.76 Million in Core Laboratories Inc. (NYSE:CLB)Raymond James Financial Inc. acquired a new stake in Core Laboratories Inc. (NYSE:CLB - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 390,554 shares of the oil and gas compaApril 26, 2025 | marketbeat.comCore Laboratories (CLB) Target Price Lowered by Stifel Analyst | CLB Stock NewsApril 25, 2025 | gurufocus.comWells Fargo & Company MN Lowers Holdings in Core Laboratories Inc. (NYSE:CLB)Wells Fargo & Company MN reduced its holdings in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 22.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 216,075 shares of the oil and gas company'April 25, 2025 | marketbeat.comCore Laboratories (CLB) Maintains Steady Quarterly DividendApril 24, 2025 | gurufocus.comCore Laboratories (CLB) Q1 Revenue Misses Expectations Amid Geopolitical Challenges | CLB Stock NewsApril 23, 2025 | gurufocus.comCore Laboratories Inc Reports Q1 2025 Earnings: EPS at $0.14, Revenue at $123. ...April 23, 2025 | gurufocus.comCore Laboratories Reports Q1 2025 Financial ResultsApril 23, 2025 | tipranks.comCore Laboratories (CLB) Q1 Revenue Misses Expectations Amid Geopolitical Challenges | CLB Stock NewsApril 23, 2025 | gurufocus.comExamining the Future: Core Laboratories's Earnings OutlookApril 23, 2025 | benzinga.comCore Laboratories Q1 2025 Earnings PreviewApril 23, 2025 | msn.com26,777 Shares in Core Laboratories Inc. (NYSE:CLB) Bought by Franklin Resources Inc.Franklin Resources Inc. purchased a new stake in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 26,777 shares of the oil and gas company's stock, valued atApril 20, 2025 | marketbeat.comRussell Investments Group Ltd. Boosts Stock Position in Core Laboratories Inc. (NYSE:CLB)Russell Investments Group Ltd. increased its holdings in Core Laboratories Inc. (NYSE:CLB - Free Report) by 27.4% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 212,823 shares of the oil and gas company's stock after purchasing an additional 45,739April 18, 2025 | marketbeat.comCore Laboratories (NYSE:CLB) Price Target Cut to $15.00 by Analysts at Stifel NicolausStifel Nicolaus reduced their price objective on shares of Core Laboratories from $19.00 to $15.00 and set a "hold" rating for the company in a research report on Tuesday.April 17, 2025 | marketbeat.comCore Laboratories (CLB) Projected to Post Quarterly Earnings on WednesdayCore Laboratories (NYSE:CLB) will be releasing earnings after the market closes on Wednesday, April 23, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=560071)April 17, 2025 | marketbeat.comNorges Bank Acquires Shares of 110,328 Core Laboratories Inc. (NYSE:CLB)Norges Bank bought a new position in Core Laboratories Inc. (NYSE:CLB - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 110,328 shares of the oil and gas company's stock, valued at approximately $1,910,000. Norges Bank ownApril 14, 2025 | marketbeat.comVanguard Group Inc. Sells 28,123 Shares of Core Laboratories Inc. (NYSE:CLB)Vanguard Group Inc. reduced its stake in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 0.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,591,218 shares of the oil and gas company's stock after selliApril 12, 2025 | marketbeat.comCore Laboratories (NYSE:CLB) Sets New 12-Month Low - Here's WhyCore Laboratories (NYSE:CLB) Hits New 52-Week Low - Here's What HappenedApril 11, 2025 | marketbeat.comTrexquant Investment LP Trims Holdings in Core Laboratories Inc. (NYSE:CLB)Trexquant Investment LP lessened its stake in Core Laboratories Inc. (NYSE:CLB - Free Report) by 34.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 102,951 shares of the oil and gas company's stock after seApril 11, 2025 | marketbeat.comCore Laboratories (NYSE:CLB) Trading Down 7.2% - What's Next?Core Laboratories (NYSE:CLB) Trading Down 7.2% - Here's WhyApril 10, 2025 | marketbeat.comCore Laboratories (NYSE:CLB) Sets New 1-Year Low - What's Next?Core Laboratories (NYSE:CLB) Hits New 12-Month Low - What's Next?April 5, 2025 | marketbeat.comQ1 Earnings Estimate for CLB Issued By Zacks ResearchCore Laboratories Inc. (NYSE:CLB - Free Report) - Equities research analysts at Zacks Research issued their Q1 2025 earnings per share (EPS) estimates for Core Laboratories in a report released on Wednesday, March 26th. Zacks Research analyst T. Saha forecasts that the oil and gas company will eaMarch 31, 2025 | marketbeat.comZacks Research Cuts Earnings Estimates for Core LaboratoriesCore Laboratories Inc. (NYSE:CLB - Free Report) - Stock analysts at Zacks Research lowered their Q2 2025 EPS estimates for Core Laboratories in a research report issued on Wednesday, March 26th. Zacks Research analyst T. Saha now expects that the oil and gas company will earn $0.21 per share forMarch 29, 2025 | marketbeat.comCORE LABORATORIES ANNOUNCES TIMING OF FIRST QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALLMarch 24, 2025 | finance.yahoo.com41,381 Shares in Core Laboratories Inc. (NYSE:CLB) Purchased by Intech Investment Management LLCIntech Investment Management LLC purchased a new stake in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 41,381 shares of the oil and gas company's stock, valMarch 24, 2025 | marketbeat.comRaymond James Financial Inc. Takes Position in Core Laboratories Inc. (NYSE:CLB)Raymond James Financial Inc. bought a new position in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 390,554 shares of the oil andMarch 24, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Lowers Holdings in Core Laboratories Inc. (NYSE:CLB)Charles Schwab Investment Management Inc. lowered its stake in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 5.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 499,299 shares of the oil andMarch 24, 2025 | marketbeat.comCore Laboratories Inc. (NYSE:CLB) Stake Boosted by AmundiAmundi grew its stake in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 194.8% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 32,968 shares of the oil and gas company's stock aMarch 21, 2025 | marketbeat.comReturns On Capital At Core Laboratories (NYSE:CLB) Paint A Concerning PictureMarch 17, 2025 | uk.finance.yahoo.comRoyce & Associates LP Reduces Holdings in Core Laboratories Inc. (NYSE:CLB)Royce & Associates LP lowered its position in Core Laboratories Inc. (NYSE:CLB - Free Report) by 5.1% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 969,128 shares of the oil and gas company's stock after selling 51,993 shares during tMarch 17, 2025 | marketbeat.comBank of New York Mellon Corp Reduces Stock Position in Core Laboratories Inc. (NYSE:CLB)Bank of New York Mellon Corp decreased its holdings in Core Laboratories Inc. (NYSE:CLB - Free Report) by 5.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 450,013 shares of the oil and gas company's stock after sellinMarch 16, 2025 | marketbeat.comWintrust Investments LLC Sells 28,549 Shares of Core Laboratories Inc. (NYSE:CLB)Wintrust Investments LLC decreased its holdings in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 73.8% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 10,142 shares of the oil and gas company's stock after selling 28,549 shares during the periMarch 14, 2025 | marketbeat.comCore Laboratories upgraded to Neutral from Sell at CitiMarch 12, 2025 | markets.businessinsider.comCore Laboratories (NYSE:CLB) Upgraded at CitigroupCitigroup upgraded shares of Core Laboratories from a "sell" rating to a "neutral" rating and boosted their target price for the company from $15.00 to $16.00 in a research report on Wednesday.March 12, 2025 | marketbeat.comBalanced Risk/Reward Outlook for Core Laboratories Amidst Decline and Growth OpportunitiesMarch 12, 2025 | tipranks.comCore Laboratories (NYSE:CLB) Shares Down 4.9% - Here's WhyCore Laboratories (NYSE:CLB) Stock Price Down 4.9% - Should You Sell?March 6, 2025 | marketbeat.comCore Laboratories (NYSE:CLB) Hits New 52-Week Low - What's Next?Core Laboratories (NYSE:CLB) Hits New 52-Week Low - Here's WhyMarch 6, 2025 | marketbeat.comFisher Asset Management LLC Cuts Stake in Core Laboratories Inc. (NYSE:CLB)Fisher Asset Management LLC lowered its stake in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 4.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 941,269 shares of the oil and gas cMarch 4, 2025 | marketbeat.comCore Laboratories (NYSE:CLB) Hits New 12-Month Low - Here's What HappenedCore Laboratories (NYSE:CLB) Sets New 1-Year Low - Time to Sell?March 1, 2025 | marketbeat.comCitigroup Forecasts Strong Price Appreciation for Core Laboratories (NYSE:CLB) StockCitigroup boosted their price target on Core Laboratories from $14.00 to $15.00 and gave the company a "sell" rating in a report on Thursday.February 21, 2025 | marketbeat.comCore Laboratories price target raised to $15 from $14 at CitiFebruary 20, 2025 | markets.businessinsider.comThe past five years for Core Laboratories (NYSE:CLB) investors has not been profitableFebruary 20, 2025 | finance.yahoo.com Get Core Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter. Email Address CLB Media Mentions By Week CLB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CLB News Sentiment▼0.740.67▲Average Energy News Sentiment CLB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CLB Articles This Week▼53▲CLB Articles Average Week Get Core Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RIG News LBRT News SOC News MNR News BKV News ARIS News DMLP News KRP News TALO News SDRL News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:CLB) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Core Laboratories Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Core Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.